Keeping an eye on obesity

31 July 2019
Acuity digital

How much do we really know about the association between obesity and eye health? As obesity reaches pandemic levels, Kathy Oxtoby reviews the evidence.

The implications of rising obesity on the nation’s health may have an impact on eye health. And with an NHS survey estimating that just over a quarter (28%) of children aged two to 15 in England were overweight or obese (BMI ≥ 30) in 2016 (Full Fact, 2018), the children of today – and the adults they will become – are particularly vulnerable. 

In the UK, diets are becoming worse too, sedentary lifestyles more prevalent, while obesity remains stubbornly high – more than a quarter of adults are officially classified as obese (NHS Digital, 2018) – and diabetes is on the rise, up 60% in the last decade (Diabetes UK, 2015). Just last year, the World Health Organization (WHO) warned that the UK was the third-fattest nation in Europe. The study of 53 countries in WHO’s European region found Britain rising up the obesity league tables (WHO, 2018).

So, how is obesity affecting eye health, what conditions should optometrists look out for in obese patients, and what conditions are they more likely to have? 

Sign in to continue

Forgotten password?
Register

Not already a member of the College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

The UK Eye Care Data Hub, the most up-to-date and comprehensive model of the UK’s eye care workforce and eye diseases in one place, has been expanded to almost double the number of eye conditions and update aspects of the sector workforce data.

The College of Optometrists has teamed up with road safety charity IAM RoadSmart to encourage drivers of all ages to see clearly when it comes to vision and driving standards.

Glaucoma is the second leading cause of irreversible sight loss in the UK and affects over one million people, which is predicted to rise by 100,000 cases to 1.145 million people by 2030*.